Considering your experience with Sharlife so far, how likely are you to recommend us to a friend or colleague?
Not at all likelyExtremely likely
(Optional)
AbbVie Inc.
ABBVHealth technology
$394.1B
Market Cap
Shariah Analysis
Failed
Business
Cash
Liabilities
Based on AAOIFI screening standards, AbbVie Inc. appears to be Failed.
Business Activity
FYE 2024
Non-Permissible Income (<5%)5.60%
Non-Permissible
$3.4K
Total Income
$60.2K
Revenue Breakdown
Humira
$9K
Skyrizi
$11.7K
Rinvoq
$6K
Oncology
$3.3K
Venclexta
$2.6K
Elahere
$479
Epkinly
$146
Botox Cosmetic
$2.7K
Non-Compliant: $2.7K
Juvederm
$1.2K
Botox Therapeutic
$3.3K
Vraylar
$3.3K
Duodopa
$447
Ubrelvy
$1K
Qulipta
$658
Ozurdex
$494
Lumigan/Ganfort
$429
Other Aesthetics
$1.3K
Other Neuroscience
$338
Alphagan/Combigan
$248
Restasis
$224
Other Eye Care
$847
Mavyret
$1.3K
Creon
$1.4K
Linzess/Constella
$954
All other
$3K
Interest income
Non-Operating
$648
Non-Compliant: $648
Other expense, net
Non-Operating
$3.2K
Financial Screening
FYE 2024
Cash (<30%)1.83%
Non-Shariah Cash Items
Cash And Cash Equivalents$5.5B
Other Short Term Investments$31M
Liabilities (<30%)22.15%
Non-Shariah Liabilities
Long Term Debt$60.3B
Current Debt$6.8B
Market Data
Exchange
NYSE
CurrencyUSD
CountryUnited States
Last Updated2025-12-19
Disclaimer: Shariah screening is based on the latest available financial data. Market conditions and company activities may change. Always conduct your own due diligence.
NYSE
